Trials / NCT04868916
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
Completed Observational Natural history / observational
- Sponsor
- Janssen Pharmaceutical K.K.
- Treatment
- Not listed
- Gene
- RPGR
- Conditions
- X-Linked Retinitis Pigmentosa
- Ages
- 5 Years to no upper limit
- Enrollment
- 15 participants
- Started
- 2021-07-26
- Main results expected
- 2024-04-23
- Results posted
- Not yet
- Record last updated
- 2025-04-25
What the study is testing
The purpose of the study is to identify a cohort of Japanese participants with X-linked retinitis pigmentosa (XLRP) associated with pathogenic variants in the retinitis pigmentosa GTPase regulator (RPGR) gene and to investigate their associated phenotype.
Where it runs
Japan (1)
- National Hospital Organization Tokyo Medical Center, Tokyo